Contact Information Available for logged-in reporters only Embargoed for release until December 7, 2014 10:45 AM PT / 1:45 PM ET Newswise SEATTLE, December 7, 2014 Despite recent advances in anti-epileptic drug (AED) development, many adults with epilepsy continue to struggle with seizure control. New findings from a phase 3 clinical trial (Poster 2.417) to be unveiled at the 68th Annual Meeting of the American Epilepsy Society, suggest an additional therapeutic option may be coming down the pike. Researchers from the Mid-Atlantic Epilepsy and Sleep Center and other participating medical centers performed a randomized, double-blind, placebo-controlled study in the United States and Europe on the efficacy and safety of the drug brivaracetam, an analog of the commonly used AED levetiracetam, in adults with poorly controlled partial onset seizures. This first presentation of primary study results from the latest Phase 3 brivaracetam study is highly anticipated in the epilepsy community. The two primary outcomes in this study evaluating adjunctive brivaracetam in the treatment of partial-onset seizures in adults with epilepsy were statistically significant and clinically relevant, said Dr. Pavel Klein, director, Mid-Atlantic Epilepsy and Sleep Center. The authors evaluated fixed doses of 100mg/day or 200 mg/day brivaracetam as an adjunctive treatment … Continue reading →

Doctors and patients are distressed by a plan to move Royal Berkshire Hospitals stroke unit from its purpose-built ground-floor ward. The hospital trust says it will provide improvements for elderly patients with hip fractures. The plan is to move the service from the Caversham ward, opened by the Queen in February 2006, to Woodley ward on an upper floor. It would mean reducing the number of stroke beds from 16 to 12, moving patients three storeys up and several corridors away from where they are treated, far from the hydrotherapy pool and therapy garden. In a letter to hospitals chief executive Jean OCallaghan, the staff doctors say of the stroke unit: Absence of social spaces will lead to patients remaining in their beds, will lengthen their hospital admission, waiting lists will lengthen for the service reducing efficiencies of the acute bed locations like ICU [intensive care unit] trauma and acute medical wards. The four doctors whom getreading has been asked not to name say: The move to Woodley ward does mean the Royal Berkshire Hospital will no longer meet the neuro-rehabilitation needs of the community, or the clinical needs of the neurologically impaired patients. Her Majesty the Queen watches a … Continue reading →

PUBLIC RELEASE DATE: 7-Dec-2014 Contact: Glenna Picton picton@bcm.edu 713-798-7973 Baylor College of Medicine @bcmhouston HOUSTON - (Dec. 7, 2014) - An international consortium of researchers led by Baylor College of Medicine has identified for the first time a gene associated with familial glioma (brain tumors that appear in two or more members of the same family) providing new support that certain people may be genetically predisposed to the disease. "It is widely thought amongst the clinical community that there is no association between family history and development of glioma. Because we know very little about the contributing genetic factors, when cases occur in two or more family members, it is viewed as coincidental," said Dr. Melissa Bondy, associate director of cancer prevention and population sciences at the NCI-designated Dan L. Duncan Cancer Center at Baylor College of Medicine and lead author of the report that appears in the Journal of the National Cancer Institute today. "By understanding more about the genetic link, we hope that one day we can improve treatments and preventive strategies for those with a family history of glioma." Bondy estimates that approximately five percent of brain tumors run in families. The study was conducted through the … Continue reading →

Future of Care: The Future of Stem Cell Therapy (Full Presentation) Watch our October 29, 2014 Future of Care presentation on the future of stem cell therapy featuring Dr. David Brenner, Vice Chancellor, UC San Diego Health Sciences, Paul Viviano, Chief Executive... By: UCSDHSDEV … Continue reading →

Download Medical Nanotechnology and Nanomedicine Perspectives in Nanotechnology PDF Click Here to Download : http://bit.ly/1tNYJsf. By: Brady Ibrahim … Continue reading →